Advances in pharmacotherapy continue to transform the landscape of diabetes management, offering more personalized and effective treatment options. This webinar provides an in-depth exploration of current strategies in diabetes care, with a particular focus on the role of DPP-4 inhibitors. Participants will gain insights into the clinical benefits, safety profile, and place of DPP-4 inhibitors within individualized treatment plans, especially for patients with comorbidities. Designed for HCPs, this webinar emphasizes evidence-based prescribing and the integration of novel therapies to optimize patient outcomes across the spectrum of type 2 diabetes care.